Analytical Study of Syringe and Needle Industry in GCC from 2024 to 2034

Sales of syringes and needles in GCC are set to rise at a 5.40% CAGR through 2034. Demand outlook for syringes and needles in GCC indicates crossing US$ 688.5 million in 2024. By 2034, sales projections for syringes and needles in GCC signify attaining a valuation of US$ 1,164.90 million.

Attributes Details
Industry Size of GCC in 2024 US$ 688.5 million
Expected Industry Size of GCC in 2034 US$ 1,164.90 million
Forecasted CAGR between 2024 to 2034 5.40%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Key Trends Influencing Demand through 2034

  • Proliferating Telemedicine Platforms and Remote Healthcare Delivery Models to Boost Demand

The GCC region's telemedicine and remote healthcare delivery trends are propelling demand for syringes and needles. Patients must either self-administer injections or receive injections from visiting healthcare experts as video consultations and home-based healthcare grow common. Manufacturing home-use syringes and needles with user-friendly designs and packaging intended for remote distribution can be opportunistic.

Several businesses are hopping on this trend, largely by alliances. For instance, in January 2024, e& business and Burjeel Holdings, one of the top healthcare service providers in the MENA region, made two historic collaborations aimed at changing healthcare in the UAE and beyond.

These include the introduction of a groundbreaking telemedicine services initiative and a strategic memorandum of understanding (MoU), both of which will change the landscape of healthcare delivery.

  • Government Initiatives and Regulations to Foster Innovation and Growth

Syringe and needle supply and demand in the GCC region are rising due to government-led initiatives to elevate healthcare standards and regulatory compliance. Regulations emphasizing safety-engineered equipment and conformity to quality standards foster an atmosphere favorable for innovation and revenue growth.

Manufacturers can gain a competitive edge in the heavily regulated GCC healthcare industry by showcasing compliance with regulatory standards, investing in quality management systems, and encouraging transparency and integrity in their operations.

By 2030, the Kingdom of Saudi Arabia's Council of Cooperative Health Insurance (CCHI) hopes to insure around half of the population and play a significant role in shaping the future of the healthcare industry. In 2022, Qatar enacted new legislation requiring insurance, while Oman and Bahrain likewise pursued universal health coverage.

  • Expanding Healthcare Infrastructure in the GCC Region Leads to a Surge in Demand

The GCC region's healthcare infrastructure expansion offers a favorable environment for growth. Demand for medical supplies is rising with governments prioritizing a robust healthcare infrastructure to meet the needs of urban and expanding populations. Syringe and needle manufacturers can benefit by forming strategic connections with regional distributors and having flexible production capabilities to gain a firm footing in the GCC region.

In March 2024, the Ministry of Health and Prevention (MoHAP) launched the Patient Safety Friendly Hospitals program. This initiative is a key step toward ensuring the provision of high-quality healthcare services in accordance with global best practices.

The program, launched in partnership with the World Health Organization (WHO), seeks to promote patient safety by developing recognized standards that improve hospital performance. Providing syringe and needle supplies in such initiatives can benefit businesses in this industry.

Key Insights - Highlights on the Emerging Opportunities in the GCC Syringe and Needle Industry

  • GCC countries, specifically Saudi Arabia and the United Arab Emirates, are becoming popular travel destinations for medical tourists looking for high-quality medical care. Manufacturers of syringes and needles can boost revenues by providing top-notch medical equipment to clinics and hospitals that treat patients worldwide. This will help in broadening their global reach.
  • Manufacturers can satisfy the particular demands of pediatric and geriatric patients by developing age-appropriate injectable devices with safety features, ergonomic designs, and possibilities for dose modification. This can address an unmet demand and improve patient satisfaction and compliance.
  • The GCC region is witnessing a rise in biological medicines and the prevalence of chronic illnesses. This presents a potential for manufacturers to deliver specialty syringes and needles designed specifically for the administration of more complex pharmaceuticals.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise insights

Hypodermic Continues to be the Leading Product in the Region

Leading Product for Syringes and Needles in GCC Hypodermic
Total Value Share (2024) 85.40%

Chronic conditions, including diabetes, heart disease, and respiratory issues, are becoming more common in GCC countries. According to the International Diabetes Federation (IDF), most of the Gulf Cooperation Council (GCC) countries have high prevalence rates of prediabetes (above 15%) and diabetes (above 20%).

These rates rank among the top in the world. Hypodermic syringes and needles are in high demand as the principal drug delivery tool since managing these disorders requires numerous injections of insulin and other therapeutic agents.

Hypodermic syringes and needles are favored in healthcare settings because of their safety features, precision, and convenience. In order to reduce the risk of contamination, prescription mistakes, and needlestick injuries, healthcare practitioners in the GCC region are using these in response to an increasing focus on patient safety and infection control.

Disposable Segment Based on Usability Gains Top Shares

Leading Usability for Syringes and Needles in GCC Disposable
Total Value Share (2024) 80.30%

GCC countries invest in health promotion initiatives, screening programs, and immunization campaigns as preventative healthcare measures. Disposable syringes and needles are in high demand in this region because they make it easier to administer drugs, immunizations, and diagnostic tests safely and effectively, which is essential in supporting these programs.

Healthcare practitioners emphasize using disposable syringes and needles to reduce the risk of healthcare-associated infections (HAIs) and provide a sterile environment for patient care as infection control and patient safety become increasingly pertinent in the GCC region.

Country-wise Insights

Countries Value CAGR (2024 to 2034)
Kingdom of Saudi Arabia 5.60%
United Arab Emirates 5.70%
Qatar 5.50%
Bahrain 4.60%
Oman 5.30%

Ambitious Vision 2030 Healthcare Goals Boost Demand in the Kingdom of Saudi Arabia

Demand for syringes and needles in the Kingdom of Saudi Arabia (KSA) to amplify at a 5.60% CAGR through 2034. The Vision 2030 plan of the KSA government encompasses a range of ambitious healthcare programs designed to improve healthcare accessibility, foster innovation, and enhance infrastructure. Manufacturers can participate in hospital development projects, medical equipment procurement, and improving healthcare service delivery.

The Saudi Arabian government's decision to privatize healthcare services is creating opportunities for the private sector to engage and invest in the healthcare sector. Modernizing medical facilities, adopting advanced equipment and upgrading medical equipment are all priorities for private healthcare providers.

Free Zone can be Opportunistic for Raising Sales in the United Arab Emirates

Sales of syringes and needles in the United Arab Emirates (UAE) to surge at a 5.70% CAGR through 2034. The free zones in the UAE provide a business-friendly atmosphere with tax breaks, streamlined regulations, and access to top-notch infrastructure.

Free zones like Dubai Healthcare City (DHCC) and the Khalifa Industrial Zone (KIZAD) in Abu Dhabi provide expedited procedures for producing, distributing, and exporting medical products, including needles and syringes. Manufacturers can boost competitiveness in the UAE and abroad, maximize supply chain efficiency, and save operating costs by taking advantage of free zone benefits.

Emphasis on Wellness Tourism and Sports Medicine Bolsters Expansion in Qatar

The syringe and needle industry expansion in Qatar is estimated at a 5.50% CAGR through 2034. Manufacturers of syringes and needles have an opportunity to produce specialized medical equipment for sports injury management, rehabilitation, and wellness therapies, given Qatar's expanding focus on sports medicine and wellness tourism.

There is a need for top-notch medical supplies to assist athletes' healthcare demands because Qatar organizes important sports events like the World Cup and the Qatar National Sports Day. Manufacturers can tweak their offerings to fit the needs of wellness centers and sports medicine professionals, taking advantage of an exclusive niche and enhancing Qatar's stature as a sports and wellness destination.

Focus on Healthcare Quality Accreditation Surges Demand in Bahrain

Demand for syringes and needles in Bahrain to rise at a 4.60% CAGR through 2034. Internationally recognized health and safety standards for syringes and needles are in high demand due to Bahrain's emphasis on regulatory compliance and healthcare quality accreditation.

In order to prove their dedication to quality and patient safety, Bahraini healthcare institutions apply for certification from groups like the Health Authority Bahrain (NQVHA) and the Joint Commission International (JCI).

Manufacturers can set themselves apart from the competition by securing the necessary endorsements and certifications, which will help them establish credibility as reliable medical device providers in Bahrain.

Rising Chronic Disease Burden Boosts Sales in Oman

Sales of syringes and needles in Oman to increase at a 5.30% CAGR through 2034. The prevalence of chronic diseases, including cardiovascular disease, diabetes, and respiratory disorders, is rising in Oman. In Oman, 40.3% of people have hypertension, 24.1% have a BMI of obesity, 33.6% have total cholesterol, and anemia affects 32.2% of non-pregnant women and 20% of men.

The management of several chronic health conditions necessitates routine injections, which increases its demand in medical institutions and home care environments. It is an opportunity for manufacturers to fulfill the unique needs of Oman's healthcare system and populace by providing a selection of specialty syringes and needles that are made for accurate dose administration and patient comfort.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

The syringe and needle industry in the GCC region is extremely competitive, with numerous established global businesses competing alongside regional players. Becton, Dickinson, and Company (BD) is an industry leader, relying on its large product range, robust distribution network, and sterling reputation to stay ahead.

Terumo Corporation, Smiths Medical, and Nipro Corporation constitute the top rivals contending for industry share, with each offering a varied selection of syringes and needles tailored to different medical specializations and uses.

Recent Developments

  • In February 2023, Venus Remedies Ltd., a leading research-based pharmaceutical company, received a good manufacturing practices (GMP) certification from Saudi Arabia.
  • In September 2022, BD (Becton, Dickinson, and Company), a renowned worldwide medical technology firm, launched a next-generation glass pre-fillable syringe (PFS) that sets a new benchmark for vaccine PFS performance, with new and tighter criteria for processability, cosmetics, contamination, and integrity.

Key Players in the Syringe and Needle Industry in GCC

  • Becton, Dickinson and Company (BD)
  • Terumo Corporation
  • Smiths Medical
  • Nipro Corporation
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Gerresheimer AG
  • Hindustan Syringes & Medical Devices Ltd. (HMD)
  • Medtronic plc
  • Fresenius SE & Co. KGaA

Scope of the Report

Attribute Details
Estimated Industry Size in 2024 US$ 688.5 million
Projected Industry Size by 2034 US$ 1,164.90 million
Anticipated CAGR between 2024 to 2034 5.40% CAGR
Historical Analysis of Demand for Syringes and Needles in GCC 2019 to 2023
Demand Forecast for Syringes and Needles in GCC 2024 to 2034
Report Coverage Industry Size, Industry Trends, Analysis of Key Factors Influencing Syringes and Needles in GCC, Insights on Global Players and their Industry Strategy in GCC, Ecosystem Analysis of Local and Regional GCC Manufacturers
Key Countries Analyzed while Studying Opportunities in Syringes and Needles in GCC Kingdom of Saudi Arabia (KSA), United Arab Emirates (UAE), Qatar, Bahrain, Oman, Kuwait
Key Companies Profiled Becton, Dickinson and Company (BD); Terumo Corporation; Smiths Medical; Nipro Corporation; B. Braun Melsungen AG; Cardinal Health, Inc.; Gerresheimer AG; Hindustan Syringes & Medical Devices Ltd. (HMD); Medtronic plc; Fresenius SE & Co. KGaA

Key Segments

By Product:

  • Oral
  • Hypodermic
    • Standard
    • Special Purpose
      • Insulin
      • Tuberculin
      • Other Special Purpose
      • Angiographic

By Usability:

  • Disposable
  • Reusable

By Material:

  • Glass
  • Polymer

By End User:

  • Hospital
  • Blood Collection Center
  • Diabetic Care Center
  • Veterinary Care Center
  • Others

By Country:

  • Kingdom of Saudi Arabia (KSA)
  • United Arab Emirates (UAE)
  • Qatar
  • Bahrain
  • Oman
  • Kuwait

Frequently Asked Questions

How Rapidly Is the Demand for Syringes and Needles in GCC Growing?  

The expected CAGR until 2034 stands at 5.40%. 

What is the Demand Outlook for Syringes and Needles in GCC?  

Demand in GCC is projected to reach US$ 1,164.90 million by 2034. 

Which Trends Influence the Demand for Syringes and Needles in GCC?

Rise of telemedicine influences the demand in GCC.

What Strategies are used by Syringes and Needles Manufacturers in GCC?

Manufacturers in GCC are emphasizing expansion through partnership strategies.

What is the Preferred Product for Syringes and Needles in GCC?

Hypodermic products are highly popular in the industry.

Table of Content
1. Executive Summary
    1.1. GCC Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Manufacturer
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2019 to 2023
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2024 to 2034
        5.3.1. Syringes
            5.3.1.1. Sterilizable/Reusable Syringes
            5.3.1.2. Disposable Syringes
        5.3.2. Needles
            5.3.2.1. Hypodermic
            5.3.2.2. Intravenous
            5.3.2.3. Intramuscular
            5.3.2.4. Others
    5.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023
    5.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034
6. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Usability
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Usability, 2019 to 2023
    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Usability, 2024 to 2034
        6.3.1. Disposable
        6.3.2. Reusable
    6.4. Y-o-Y Growth Trend Analysis By Usability, 2019 to 2023
    6.5. Absolute $ Opportunity Analysis By Usability, 2024 to 2034
7. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Material
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material, 2019 to 2023
    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material, 2024 to 2034
        7.3.1. Glass
        7.3.2. Polymer
    7.4. Y-o-Y Growth Trend Analysis By Material, 2019 to 2023
    7.5. Absolute $ Opportunity Analysis By Material, 2024 to 2034
8. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
    8.1. Introduction / Key Findings
    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2019 to 2023
    8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2024 to 2034
        8.3.1. Hospital
        8.3.2. Blood Collection Center
        8.3.3. Diabetic Care Center
        8.3.4. Veterinary Care Center
        8.3.5. Others
    8.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
    8.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
9. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    9.1. Introduction
    9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Country, 2019 to 2023
    9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Country, 2024 to 2034
        9.3.1. KSA
        9.3.2. UAE
        9.3.3. Qatar
        9.3.4. Oman
        9.3.5. Rest of GCC
    9.4. Market Attractiveness Analysis By Country
10. KSA Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
        10.2.1. By Region
        10.2.2. By Type
        10.2.3. By Usability
        10.2.4. By Material
        10.2.5. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Region
        10.3.2. By Type
        10.3.3. By Usability
        10.3.4. By Material
        10.3.5. By End User
    10.4. Key Takeaways
11. UAE Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
        11.2.1. By Region
        11.2.2. By Type
        11.2.3. By Usability
        11.2.4. By Material
        11.2.5. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Region
        11.3.2. By Type
        11.3.3. By Usability
        11.3.4. By Material
        11.3.5. By End User
    11.4. Key Takeaways
12. Qatar Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
        12.2.1. By Region
        12.2.2. By Type
        12.2.3. By Usability
        12.2.4. By Material
        12.2.5. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Region
        12.3.2. By Type
        12.3.3. By Usability
        12.3.4. By Material
        12.3.5. By End User
    12.4. Key Takeaways
13. Oman Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
        13.2.1. By Region
        13.2.2. By Type
        13.2.3. By Usability
        13.2.4. By Material
        13.2.5. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Region
        13.3.2. By Type
        13.3.3. By Usability
        13.3.4. By Material
        13.3.5. By End User
    13.4. Key Takeaways
14. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
        14.2.1. By Country
        14.2.2. By Type
        14.2.3. By Usability
        14.2.4. By Material
        14.2.5. By End User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Type
        14.3.3. By Usability
        14.3.4. By Material
        14.3.5. By End User
    14.4. Key Takeaways
15. Market Structure Analysis
    15.1. Competition Dashboard
    15.2. Competition Benchmarking
    15.3. Market Share Analysis of Top Players
        15.3.1. By Regional
        15.3.2. By Type
        15.3.3. By Usability
        15.3.4. By Material
        15.3.5. By End User
16. Competition Analysis
    16.1. Competition Deep Dive
        16.1.1. Becton, Dickinson and Company
            16.1.1.1. Overview
            16.1.1.2. Product Portfolio
            16.1.1.3. Profitability by Market Segments
            16.1.1.4. Sales Footprint
            16.1.1.5. Strategy Overview
                16.1.1.5.1. Marketing Strategy
                16.1.1.5.2. Product Strategy
                16.1.1.5.3. Channel Strategy
        16.1.2. Nipro Corporation
            16.1.2.1. Overview
            16.1.2.2. Product Portfolio
            16.1.2.3. Profitability by Market Segments
            16.1.2.4. Sales Footprint
            16.1.2.5. Strategy Overview
                16.1.2.5.1. Marketing Strategy
                16.1.2.5.2. Product Strategy
                16.1.2.5.3. Channel Strategy
        16.1.3. Baxter International Inc.
            16.1.3.1. Overview
            16.1.3.2. Product Portfolio
            16.1.3.3. Profitability by Market Segments
            16.1.3.4. Sales Footprint
            16.1.3.5. Strategy Overview
                16.1.3.5.1. Marketing Strategy
                16.1.3.5.2. Product Strategy
                16.1.3.5.3. Channel Strategy
        16.1.4. B. Braun Melsungen AG
            16.1.4.1. Overview
            16.1.4.2. Product Portfolio
            16.1.4.3. Profitability by Market Segments
            16.1.4.4. Sales Footprint
            16.1.4.5. Strategy Overview
                16.1.4.5.1. Marketing Strategy
                16.1.4.5.2. Product Strategy
                16.1.4.5.3. Channel Strategy
        16.1.5. Terumo Corporation
            16.1.5.1. Overview
            16.1.5.2. Product Portfolio
            16.1.5.3. Profitability by Market Segments
            16.1.5.4. Sales Footprint
            16.1.5.5. Strategy Overview
                16.1.5.5.1. Marketing Strategy
                16.1.5.5.2. Product Strategy
                16.1.5.5.3. Channel Strategy
        16.1.6. Medtronic PLC
            16.1.6.1. Overview
            16.1.6.2. Product Portfolio
            16.1.6.3. Profitability by Market Segments
            16.1.6.4. Sales Footprint
            16.1.6.5. Strategy Overview
                16.1.6.5.1. Marketing Strategy
                16.1.6.5.2. Product Strategy
                16.1.6.5.3. Channel Strategy
        16.1.7. Smiths Group PLC
            16.1.7.1. Overview
            16.1.7.2. Product Portfolio
            16.1.7.3. Profitability by Market Segments
            16.1.7.4. Sales Footprint
            16.1.7.5. Strategy Overview
                16.1.7.5.1. Marketing Strategy
                16.1.7.5.2. Product Strategy
                16.1.7.5.3. Channel Strategy
        16.1.8. Abu Dhabi Medical Devices Company
            16.1.8.1. Overview
            16.1.8.2. Product Portfolio
            16.1.8.3. Profitability by Market Segments
            16.1.8.4. Sales Footprint
            16.1.8.5. Strategy Overview
                16.1.8.5.1. Marketing Strategy
                16.1.8.5.2. Product Strategy
                16.1.8.5.3. Channel Strategy
        16.1.9. SAAPP (FZC) LLC.
            16.1.9.1. Overview
            16.1.9.2. Product Portfolio
            16.1.9.3. Profitability by Market Segments
            16.1.9.4. Sales Footprint
            16.1.9.5. Strategy Overview
                16.1.9.5.1. Marketing Strategy
                16.1.9.5.2. Product Strategy
                16.1.9.5.3. Channel Strategy
        16.1.10. IBN Sina Medical Factory
            16.1.10.1. Overview
            16.1.10.2. Product Portfolio
            16.1.10.3. Profitability by Market Segments
            16.1.10.4. Sales Footprint
            16.1.10.5. Strategy Overview
                16.1.10.5.1. Marketing Strategy
                16.1.10.5.2. Product Strategy
                16.1.10.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Recommendations

Travel and Tourism

GCC Countries Medical Tourism Market

May 2024

REP-GB-15269

309 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Industry Analysis of Syringe and Needle in GCC

Schedule a Call